nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP1A2—Carmustine—lymphatic system cancer	0.122	0.177	CbGbCtD
Clopidogrel—CYP3A5—Teniposide—lymphatic system cancer	0.11	0.159	CbGbCtD
Clopidogrel—CYP2C19—Teniposide—lymphatic system cancer	0.0887	0.129	CbGbCtD
Clopidogrel—CYP2C9—Teniposide—lymphatic system cancer	0.0737	0.107	CbGbCtD
Clopidogrel—CYP3A5—Vincristine—lymphatic system cancer	0.0529	0.0768	CbGbCtD
Clopidogrel—ABCB1—Mitoxantrone—lymphatic system cancer	0.05	0.0726	CbGbCtD
Clopidogrel—CYP3A4—Cytarabine—lymphatic system cancer	0.0435	0.0631	CbGbCtD
Clopidogrel—CYP3A4—Teniposide—lymphatic system cancer	0.0429	0.0622	CbGbCtD
Clopidogrel—ABCB1—Vincristine—lymphatic system cancer	0.0344	0.05	CbGbCtD
Clopidogrel—CYP3A4—Mitoxantrone—lymphatic system cancer	0.03	0.0435	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—lymphatic system cancer	0.0208	0.0302	CbGbCtD
Clopidogrel—CYP3A4—Vincristine—lymphatic system cancer	0.0206	0.0299	CbGbCtD
Clopidogrel—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.000581	0.00187	CcSEcCtD
Clopidogrel—Dyspnoea—Fludarabine—lymphatic system cancer	0.000579	0.00186	CcSEcCtD
Clopidogrel—Haematuria—Mitoxantrone—lymphatic system cancer	0.000577	0.00186	CcSEcCtD
Clopidogrel—Oedema peripheral—Carmustine—lymphatic system cancer	0.000576	0.00185	CcSEcCtD
Clopidogrel—Dyspepsia—Fludarabine—lymphatic system cancer	0.000571	0.00184	CcSEcCtD
Clopidogrel—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00057	0.00183	CcSEcCtD
Clopidogrel—Ulcer—Methotrexate—lymphatic system cancer	0.00057	0.00183	CcSEcCtD
Clopidogrel—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000568	0.00183	CcSEcCtD
Clopidogrel—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000565	0.00182	CcSEcCtD
Clopidogrel—Visual impairment—Carmustine—lymphatic system cancer	0.000563	0.00181	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00056	0.0018	CcSEcCtD
Clopidogrel—Fatigue—Fludarabine—lymphatic system cancer	0.000559	0.0018	CcSEcCtD
Clopidogrel—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000555	0.00179	CcSEcCtD
Clopidogrel—Hallucination—Vincristine—lymphatic system cancer	0.000555	0.00179	CcSEcCtD
Clopidogrel—Pain—Fludarabine—lymphatic system cancer	0.000555	0.00179	CcSEcCtD
Clopidogrel—Constipation—Fludarabine—lymphatic system cancer	0.000555	0.00179	CcSEcCtD
Clopidogrel—Vasculitis—Methotrexate—lymphatic system cancer	0.000552	0.00178	CcSEcCtD
Clopidogrel—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000551	0.00177	CcSEcCtD
Clopidogrel—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.000549	0.00177	CcSEcCtD
Clopidogrel—Urethral disorder—Vincristine—lymphatic system cancer	0.000547	0.00176	CcSEcCtD
Clopidogrel—Eye disorder—Carmustine—lymphatic system cancer	0.000546	0.00176	CcSEcCtD
Clopidogrel—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000546	0.00176	CcSEcCtD
Clopidogrel—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000545	0.00175	CcSEcCtD
Clopidogrel—Hypersensitivity—Teniposide—lymphatic system cancer	0.000544	0.00175	CcSEcCtD
Clopidogrel—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000543	0.00175	CcSEcCtD
Clopidogrel—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000543	0.00175	CcSEcCtD
Clopidogrel—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.000539	0.00174	CcSEcCtD
Clopidogrel—Anaemia—Bleomycin—lymphatic system cancer	0.000539	0.00173	CcSEcCtD
Clopidogrel—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000535	0.00172	CcSEcCtD
Clopidogrel—Asthenia—Teniposide—lymphatic system cancer	0.00053	0.00171	CcSEcCtD
Clopidogrel—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000527	0.0017	CcSEcCtD
Clopidogrel—Pruritus—Teniposide—lymphatic system cancer	0.000522	0.00168	CcSEcCtD
Clopidogrel—Leukopenia—Bleomycin—lymphatic system cancer	0.000522	0.00168	CcSEcCtD
Clopidogrel—Cystitis—Methotrexate—lymphatic system cancer	0.000521	0.00168	CcSEcCtD
Clopidogrel—Body temperature increased—Fludarabine—lymphatic system cancer	0.000513	0.00165	CcSEcCtD
Clopidogrel—Mental disorder—Carmustine—lymphatic system cancer	0.000512	0.00165	CcSEcCtD
Clopidogrel—Malnutrition—Carmustine—lymphatic system cancer	0.000509	0.00164	CcSEcCtD
Clopidogrel—Cough—Bleomycin—lymphatic system cancer	0.000509	0.00164	CcSEcCtD
Clopidogrel—Angiopathy—Vincristine—lymphatic system cancer	0.000506	0.00163	CcSEcCtD
Clopidogrel—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000506	0.00163	CcSEcCtD
Clopidogrel—Diarrhoea—Teniposide—lymphatic system cancer	0.000505	0.00163	CcSEcCtD
Clopidogrel—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000503	0.00162	CcSEcCtD
Clopidogrel—Chest pain—Bleomycin—lymphatic system cancer	0.000496	0.0016	CcSEcCtD
Clopidogrel—Myalgia—Bleomycin—lymphatic system cancer	0.000496	0.0016	CcSEcCtD
Clopidogrel—Back pain—Carmustine—lymphatic system cancer	0.000492	0.00158	CcSEcCtD
Clopidogrel—Mental disorder—Vincristine—lymphatic system cancer	0.000489	0.00157	CcSEcCtD
Clopidogrel—Bladder pain—Methotrexate—lymphatic system cancer	0.000487	0.00157	CcSEcCtD
Clopidogrel—Ecchymosis—Methotrexate—lymphatic system cancer	0.000487	0.00157	CcSEcCtD
Clopidogrel—Confusional state—Bleomycin—lymphatic system cancer	0.00048	0.00154	CcSEcCtD
Clopidogrel—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000478	0.00154	CcSEcCtD
Clopidogrel—Oedema—Bleomycin—lymphatic system cancer	0.000476	0.00153	CcSEcCtD
Clopidogrel—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000476	0.00153	CcSEcCtD
Clopidogrel—Infection—Bleomycin—lymphatic system cancer	0.000473	0.00152	CcSEcCtD
Clopidogrel—Anaemia—Carmustine—lymphatic system cancer	0.00047	0.00151	CcSEcCtD
Clopidogrel—Back pain—Vincristine—lymphatic system cancer	0.00047	0.00151	CcSEcCtD
Clopidogrel—Vomiting—Teniposide—lymphatic system cancer	0.000469	0.00151	CcSEcCtD
Clopidogrel—Asthenia—Fludarabine—lymphatic system cancer	0.000466	0.0015	CcSEcCtD
Clopidogrel—Rash—Teniposide—lymphatic system cancer	0.000466	0.0015	CcSEcCtD
Clopidogrel—Dermatitis—Teniposide—lymphatic system cancer	0.000465	0.0015	CcSEcCtD
Clopidogrel—Headache—Teniposide—lymphatic system cancer	0.000463	0.00149	CcSEcCtD
Clopidogrel—Pruritus—Fludarabine—lymphatic system cancer	0.000459	0.00148	CcSEcCtD
Clopidogrel—Back pain—Mitoxantrone—lymphatic system cancer	0.000458	0.00147	CcSEcCtD
Clopidogrel—Leukopenia—Carmustine—lymphatic system cancer	0.000455	0.00147	CcSEcCtD
Clopidogrel—Anaemia—Vincristine—lymphatic system cancer	0.000449	0.00145	CcSEcCtD
Clopidogrel—Hypotension—Bleomycin—lymphatic system cancer	0.000445	0.00143	CcSEcCtD
Clopidogrel—Diarrhoea—Fludarabine—lymphatic system cancer	0.000444	0.00143	CcSEcCtD
Clopidogrel—Hypertension—Carmustine—lymphatic system cancer	0.000439	0.00141	CcSEcCtD
Clopidogrel—Nausea—Teniposide—lymphatic system cancer	0.000439	0.00141	CcSEcCtD
Clopidogrel—Anaemia—Mitoxantrone—lymphatic system cancer	0.000437	0.00141	CcSEcCtD
Clopidogrel—Vertigo—Vincristine—lymphatic system cancer	0.000436	0.0014	CcSEcCtD
Clopidogrel—Leukopenia—Vincristine—lymphatic system cancer	0.000435	0.0014	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000433	0.0014	CcSEcCtD
Clopidogrel—Chest pain—Carmustine—lymphatic system cancer	0.000433	0.00139	CcSEcCtD
Clopidogrel—Myalgia—Carmustine—lymphatic system cancer	0.000433	0.00139	CcSEcCtD
Clopidogrel—Anxiety—Carmustine—lymphatic system cancer	0.000432	0.00139	CcSEcCtD
Clopidogrel—Paraesthesia—Bleomycin—lymphatic system cancer	0.000427	0.00138	CcSEcCtD
Clopidogrel—Dyspnoea—Bleomycin—lymphatic system cancer	0.000424	0.00137	CcSEcCtD
Clopidogrel—Renal failure acute—Methotrexate—lymphatic system cancer	0.000424	0.00136	CcSEcCtD
Clopidogrel—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000423	0.00136	CcSEcCtD
Clopidogrel—Hypertension—Vincristine—lymphatic system cancer	0.000419	0.00135	CcSEcCtD
Clopidogrel—Confusional state—Carmustine—lymphatic system cancer	0.000419	0.00135	CcSEcCtD
Clopidogrel—Oedema—Carmustine—lymphatic system cancer	0.000415	0.00134	CcSEcCtD
Clopidogrel—Myalgia—Vincristine—lymphatic system cancer	0.000414	0.00133	CcSEcCtD
Clopidogrel—Cough—Mitoxantrone—lymphatic system cancer	0.000413	0.00133	CcSEcCtD
Clopidogrel—Infection—Carmustine—lymphatic system cancer	0.000413	0.00133	CcSEcCtD
Clopidogrel—Vomiting—Fludarabine—lymphatic system cancer	0.000413	0.00133	CcSEcCtD
Clopidogrel—Rash—Fludarabine—lymphatic system cancer	0.000409	0.00132	CcSEcCtD
Clopidogrel—Dermatitis—Fludarabine—lymphatic system cancer	0.000409	0.00132	CcSEcCtD
Clopidogrel—Hypertension—Mitoxantrone—lymphatic system cancer	0.000408	0.00131	CcSEcCtD
Clopidogrel—Pain—Bleomycin—lymphatic system cancer	0.000407	0.00131	CcSEcCtD
Clopidogrel—Headache—Fludarabine—lymphatic system cancer	0.000407	0.00131	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000404	0.0013	CcSEcCtD
Clopidogrel—Myalgia—Mitoxantrone—lymphatic system cancer	0.000403	0.0013	CcSEcCtD
Clopidogrel—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000403	0.0013	CcSEcCtD
Clopidogrel—Chest pain—Mitoxantrone—lymphatic system cancer	0.000403	0.0013	CcSEcCtD
Clopidogrel—Anxiety—Mitoxantrone—lymphatic system cancer	0.000401	0.00129	CcSEcCtD
Clopidogrel—Oedema—Vincristine—lymphatic system cancer	0.000396	0.00128	CcSEcCtD
Clopidogrel—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000396	0.00128	CcSEcCtD
Clopidogrel—Infection—Vincristine—lymphatic system cancer	0.000394	0.00127	CcSEcCtD
Clopidogrel—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000392	0.00126	CcSEcCtD
Clopidogrel—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000391	0.00126	CcSEcCtD
Clopidogrel—Confusional state—Mitoxantrone—lymphatic system cancer	0.000389	0.00125	CcSEcCtD
Clopidogrel—Nervous system disorder—Vincristine—lymphatic system cancer	0.000389	0.00125	CcSEcCtD
Clopidogrel—Hypotension—Carmustine—lymphatic system cancer	0.000388	0.00125	CcSEcCtD
Clopidogrel—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000386	0.00124	CcSEcCtD
Clopidogrel—Oedema—Mitoxantrone—lymphatic system cancer	0.000386	0.00124	CcSEcCtD
Clopidogrel—Nausea—Fludarabine—lymphatic system cancer	0.000385	0.00124	CcSEcCtD
Clopidogrel—Infection—Mitoxantrone—lymphatic system cancer	0.000384	0.00123	CcSEcCtD
Clopidogrel—Shock—Mitoxantrone—lymphatic system cancer	0.00038	0.00122	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000378	0.00122	CcSEcCtD
Clopidogrel—Urticaria—Bleomycin—lymphatic system cancer	0.000378	0.00122	CcSEcCtD
Clopidogrel—Body temperature increased—Bleomycin—lymphatic system cancer	0.000376	0.00121	CcSEcCtD
Clopidogrel—Insomnia—Carmustine—lymphatic system cancer	0.000376	0.00121	CcSEcCtD
Clopidogrel—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000375	0.00121	CcSEcCtD
Clopidogrel—Paraesthesia—Carmustine—lymphatic system cancer	0.000373	0.0012	CcSEcCtD
Clopidogrel—Hypotension—Vincristine—lymphatic system cancer	0.00037	0.00119	CcSEcCtD
Clopidogrel—Dyspnoea—Carmustine—lymphatic system cancer	0.00037	0.00119	CcSEcCtD
Clopidogrel—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000361	0.00116	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000361	0.00116	CcSEcCtD
Clopidogrel—Hypotension—Mitoxantrone—lymphatic system cancer	0.000361	0.00116	CcSEcCtD
Clopidogrel—Insomnia—Vincristine—lymphatic system cancer	0.000359	0.00115	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000359	0.00115	CcSEcCtD
Clopidogrel—Paraesthesia—Vincristine—lymphatic system cancer	0.000356	0.00115	CcSEcCtD
Clopidogrel—Pain—Carmustine—lymphatic system cancer	0.000355	0.00114	CcSEcCtD
Clopidogrel—Constipation—Carmustine—lymphatic system cancer	0.000355	0.00114	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000352	0.00113	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000352	0.00113	CcSEcCtD
Clopidogrel—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000351	0.00113	CcSEcCtD
Clopidogrel—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000347	0.00112	CcSEcCtD
Clopidogrel—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000344	0.00111	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000342	0.0011	CcSEcCtD
Clopidogrel—Feeling abnormal—Carmustine—lymphatic system cancer	0.000342	0.0011	CcSEcCtD
Clopidogrel—Fatigue—Vincristine—lymphatic system cancer	0.000342	0.0011	CcSEcCtD
Clopidogrel—Asthenia—Bleomycin—lymphatic system cancer	0.000341	0.0011	CcSEcCtD
Clopidogrel—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00034	0.00109	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00034	0.00109	CcSEcCtD
Clopidogrel—Constipation—Vincristine—lymphatic system cancer	0.000339	0.00109	CcSEcCtD
Clopidogrel—Pain—Vincristine—lymphatic system cancer	0.000339	0.00109	CcSEcCtD
Clopidogrel—Asthma—Methotrexate—lymphatic system cancer	0.000338	0.00109	CcSEcCtD
Clopidogrel—Pruritus—Bleomycin—lymphatic system cancer	0.000337	0.00108	CcSEcCtD
Clopidogrel—Eosinophilia—Methotrexate—lymphatic system cancer	0.000335	0.00108	CcSEcCtD
Clopidogrel—Fatigue—Mitoxantrone—lymphatic system cancer	0.000333	0.00107	CcSEcCtD
Clopidogrel—Pancreatitis—Methotrexate—lymphatic system cancer	0.000332	0.00107	CcSEcCtD
Clopidogrel—Pain—Mitoxantrone—lymphatic system cancer	0.00033	0.00106	CcSEcCtD
Clopidogrel—Constipation—Mitoxantrone—lymphatic system cancer	0.00033	0.00106	CcSEcCtD
Clopidogrel—Abdominal pain—Carmustine—lymphatic system cancer	0.000328	0.00106	CcSEcCtD
Clopidogrel—Body temperature increased—Carmustine—lymphatic system cancer	0.000328	0.00106	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000324	0.00104	CcSEcCtD
Clopidogrel—Pancytopenia—Methotrexate—lymphatic system cancer	0.000321	0.00103	CcSEcCtD
Clopidogrel—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000318	0.00102	CcSEcCtD
Clopidogrel—Neutropenia—Methotrexate—lymphatic system cancer	0.000316	0.00102	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000316	0.00102	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000314	0.00101	CcSEcCtD
Clopidogrel—Abdominal pain—Vincristine—lymphatic system cancer	0.000313	0.00101	CcSEcCtD
Clopidogrel—Body temperature increased—Vincristine—lymphatic system cancer	0.000313	0.00101	CcSEcCtD
Clopidogrel—Urticaria—Mitoxantrone—lymphatic system cancer	0.000307	0.000987	CcSEcCtD
Clopidogrel—Hypersensitivity—Carmustine—lymphatic system cancer	0.000306	0.000985	CcSEcCtD
Clopidogrel—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000305	0.000982	CcSEcCtD
Clopidogrel—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000305	0.000982	CcSEcCtD
Clopidogrel—Pneumonia—Methotrexate—lymphatic system cancer	0.000303	0.000976	CcSEcCtD
Clopidogrel—Vomiting—Bleomycin—lymphatic system cancer	0.000302	0.000974	CcSEcCtD
Clopidogrel—Depression—Methotrexate—lymphatic system cancer	0.000301	0.000968	CcSEcCtD
Clopidogrel—Rash—Bleomycin—lymphatic system cancer	0.0003	0.000966	CcSEcCtD
Clopidogrel—Dermatitis—Bleomycin—lymphatic system cancer	0.0003	0.000965	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000299	0.000963	CcSEcCtD
Clopidogrel—Asthenia—Carmustine—lymphatic system cancer	0.000298	0.000959	CcSEcCtD
Clopidogrel—Renal failure—Methotrexate—lymphatic system cancer	0.000296	0.000954	CcSEcCtD
Clopidogrel—Stomatitis—Methotrexate—lymphatic system cancer	0.000294	0.000946	CcSEcCtD
Clopidogrel—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000293	0.000944	CcSEcCtD
Clopidogrel—Hypersensitivity—Vincristine—lymphatic system cancer	0.000292	0.00094	CcSEcCtD
Clopidogrel—Haematuria—Methotrexate—lymphatic system cancer	0.000288	0.000926	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000285	0.000918	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—lymphatic system cancer	0.000284	0.000916	CcSEcCtD
Clopidogrel—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000284	0.000916	CcSEcCtD
Clopidogrel—Asthenia—Vincristine—lymphatic system cancer	0.000284	0.000916	CcSEcCtD
Clopidogrel—Diarrhoea—Carmustine—lymphatic system cancer	0.000284	0.000915	CcSEcCtD
Clopidogrel—Nausea—Bleomycin—lymphatic system cancer	0.000283	0.00091	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000281	0.000906	CcSEcCtD
Clopidogrel—Asthenia—Mitoxantrone—lymphatic system cancer	0.000277	0.000892	CcSEcCtD
Clopidogrel—Dizziness—Carmustine—lymphatic system cancer	0.000275	0.000884	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—lymphatic system cancer	0.000272	0.000876	CcSEcCtD
Clopidogrel—Diarrhoea—Vincristine—lymphatic system cancer	0.000271	0.000873	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—lymphatic system cancer	0.000271	0.000872	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—lymphatic system cancer	0.000271	0.000872	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000267	0.000861	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—lymphatic system cancer	0.000265	0.000854	CcSEcCtD
Clopidogrel—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000264	0.00085	CcSEcCtD
Clopidogrel—Vomiting—Carmustine—lymphatic system cancer	0.000264	0.00085	CcSEcCtD
Clopidogrel—Dizziness—Vincristine—lymphatic system cancer	0.000262	0.000844	CcSEcCtD
Clopidogrel—Rash—Carmustine—lymphatic system cancer	0.000262	0.000843	CcSEcCtD
Clopidogrel—Dermatitis—Carmustine—lymphatic system cancer	0.000262	0.000842	CcSEcCtD
Clopidogrel—Visual impairment—Methotrexate—lymphatic system cancer	0.000261	0.00084	CcSEcCtD
Clopidogrel—Headache—Carmustine—lymphatic system cancer	0.00026	0.000837	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000256	0.000824	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—lymphatic system cancer	0.000253	0.000814	CcSEcCtD
Clopidogrel—Tinnitus—Methotrexate—lymphatic system cancer	0.000252	0.000813	CcSEcCtD
Clopidogrel—Vomiting—Vincristine—lymphatic system cancer	0.000252	0.000811	CcSEcCtD
Clopidogrel—Rash—Vincristine—lymphatic system cancer	0.00025	0.000805	CcSEcCtD
Clopidogrel—Dermatitis—Vincristine—lymphatic system cancer	0.00025	0.000804	CcSEcCtD
Clopidogrel—Headache—Vincristine—lymphatic system cancer	0.000248	0.000799	CcSEcCtD
Clopidogrel—Nausea—Carmustine—lymphatic system cancer	0.000247	0.000794	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—lymphatic system cancer	0.000246	0.000791	CcSEcCtD
Clopidogrel—Vomiting—Mitoxantrone—lymphatic system cancer	0.000245	0.00079	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—lymphatic system cancer	0.000245	0.000787	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000244	0.000785	CcSEcCtD
Clopidogrel—Rash—Mitoxantrone—lymphatic system cancer	0.000243	0.000784	CcSEcCtD
Clopidogrel—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000243	0.000783	CcSEcCtD
Clopidogrel—Headache—Mitoxantrone—lymphatic system cancer	0.000242	0.000779	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—lymphatic system cancer	0.000237	0.000764	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—lymphatic system cancer	0.000236	0.000759	CcSEcCtD
Clopidogrel—Nausea—Vincristine—lymphatic system cancer	0.000235	0.000758	CcSEcCtD
Clopidogrel—Nausea—Mitoxantrone—lymphatic system cancer	0.000229	0.000738	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—lymphatic system cancer	0.000228	0.000734	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—lymphatic system cancer	0.000218	0.000701	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—lymphatic system cancer	0.000212	0.000682	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—lymphatic system cancer	0.000211	0.000679	CcSEcCtD
Clopidogrel—Cough—Methotrexate—lymphatic system cancer	0.000206	0.000662	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—lymphatic system cancer	0.000201	0.000646	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—lymphatic system cancer	0.000201	0.000646	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—lymphatic system cancer	0.000201	0.000646	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000199	0.000641	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—lymphatic system cancer	0.000194	0.000624	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000192	0.000619	CcSEcCtD
Clopidogrel—Infection—Methotrexate—lymphatic system cancer	0.000191	0.000615	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000189	0.000607	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—lymphatic system cancer	0.000187	0.000601	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—lymphatic system cancer	0.00018	0.000579	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000175	0.000564	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—lymphatic system cancer	0.000174	0.00056	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—lymphatic system cancer	0.000173	0.000556	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—lymphatic system cancer	0.000171	0.000552	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—lymphatic system cancer	0.000169	0.000545	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000166	0.000535	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—lymphatic system cancer	0.000166	0.000534	CcSEcCtD
Clopidogrel—Pain—Methotrexate—lymphatic system cancer	0.000164	0.00053	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000159	0.00051	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000157	0.000506	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—lymphatic system cancer	0.000153	0.000492	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—lymphatic system cancer	0.000152	0.000489	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—lymphatic system cancer	0.000152	0.000489	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000142	0.000456	CcSEcCtD
Clopidogrel—Asthenia—Methotrexate—lymphatic system cancer	0.000138	0.000444	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—lymphatic system cancer	0.000136	0.000438	CcSEcCtD
Clopidogrel—Diarrhoea—Methotrexate—lymphatic system cancer	0.000132	0.000424	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—lymphatic system cancer	0.000127	0.000409	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—lymphatic system cancer	0.000122	0.000394	CcSEcCtD
Clopidogrel—Rash—Methotrexate—lymphatic system cancer	0.000121	0.00039	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—lymphatic system cancer	0.000121	0.00039	CcSEcCtD
Clopidogrel—Headache—Methotrexate—lymphatic system cancer	0.000121	0.000388	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—lymphatic system cancer	0.000114	0.000368	CcSEcCtD
